Company

Uscom Limited

Headquarters: Sydney, NSW, Australia

Employees: 35

CEO: Dr. Robert Allan Phillips DMU, Ph.D.(Med), AMS, MPhil (Med), FASE, FIR

ASX: UCM +3.85%

Market Cap

A$7.8 Million

AUD as of Jan. 1, 2024

US$5.3 Million

Market Cap History

Uscom Limited market capitalization over time

Evolution of Uscom Limited market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Uscom Limited

Detailed Description

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. The company provides the SpiroSonic AIR, a digital home care spirometer which feeds digital lung function signals through a phone app; and Ventitest, a digital ultrasonic ventilator testing solution for testing ventilators. It serves hospitals and other medical care locations through a network of distribution partners. The company was formerly known as Uscom Pty Limited and changed its name to Uscom Limited in October 2003. The company was incorporated in 1999 and is headquartered in Sydney, Australia.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Uscom Limited has the following listings and related stock indices.


Stock: ASX: UCM wb_incandescent

Details

Headquarters:

66 Clarence Street

Suite 2 Level 8

Sydney, NSW 2000

Australia

Phone: 61 2 9247 4144

Fax: 61 2 9247 8157